Search by Drug Name or NDC
NDC 78206-0158-01 REMERONSOLTAB 30 mg/1 Details
REMERONSOLTAB 30 mg/1
REMERONSOLTAB is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Organon LLC. The primary component is MIRTAZAPINE.
MedlinePlus Drug Summary
Mirtazapine is used to treat depression. Mirtazapine is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain to maintain mental balance.
Related Packages: 78206-0158-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Mirtazapine
Product Information
| NDC | 78206-0158 |
|---|---|
| Product ID | 78206-158_9ca37cbe-04af-433a-940a-326169418b9d |
| Associated GPIs | 58030050007230 |
| GCN Sequence Number | 047454 |
| GCN Sequence Number Description | mirtazapine TAB RAPDIS 30 MG ORAL |
| HIC3 | H7B |
| HIC3 Description | ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS |
| GCN | 12531 |
| HICL Sequence Number | 011505 |
| HICL Sequence Number Description | MIRTAZAPINE |
| Brand/Generic | Brand |
| Proprietary Name | REMERONSOLTAB |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | MIRTAZAPINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | MIRTAZAPINE |
| Labeler Name | Organon LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021208 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 78206-0158-01 (78206015801)
| NDC Package Code | 78206-158-01 |
|---|---|
| Billing NDC | 78206015801 |
| Package | 5 BLISTER PACK in 1 BOX (78206-158-01) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (78206-158-99) |
| Marketing Start Date | 2021-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |